Scientists think there is one cause behind worrying rise of lung cancer in people that have never smoked
Scientists believe that air pollution could be a major cause behind the rise in global lung cancer cases in people that have ...
Lung cancer on the rise among ‘never smokers’ – 9 signs to spot the ‘silent killer’
THE proportion of people diagnosed with lung cancer who’ve never smoked is increasing, the World Health Organization (WHO) ...
‘It’s working!’ Columbus cancer center is first in Georgia to administer this new therapy
Susan Williams,seated center, a patient at the John B. Amos Cancer Center in Columbus, Georgia, is receiving a new cancer ...
Morningstar8d
Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Small-cell lung cancer: ESMO Clinical Practice Guidelines ... is the first anti-PD-1 mAb for the first-line treatment of SCLC and has been approved in China, the EU and several SEA countries.
The Lancet10d
Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study
Estimated geographical and temporal distribution of lung-cancer incidence varied across the four main subtypes worldwide. Our ...
Cure Today6d
Tagrisso Associated With Cardiac Side Effects in Non-Small Cell Lung Cancer
Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events ...
Healthline4d
How Does Lung Cancer Affect Appetite? 13 Tips to Combat Weight Loss
Many people with lung cancer develop anemia, especially after chemotherapy treatment. Anemia occurs when your red blood cell levels drop too low. In one 2021 study, about 32% of the people with ...
PMLiVE11d
J&J’s subcutaneous Rybrevant receives positive CHMP opinion for advanced lung cancer
The Committee for Medicinal Products for Human Use (CHMP) has recommended that the subcutaneous (SC) formulation be approved ...
Pharmabiz3d
CStone Pharma announces inclusion of Cejemly as a first-line combination therapy for NSCLC in ESMO guideline
In combination with fluoropyrimidine- and platinum-containing chemotherapy as first-line treatment for unresectable locally advanced or metastatic gastric or gastroesophageal junction (G/GEJ) ...
Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Shanghai Henlius Biotech, Inc. (2696.HK) announced that its anti-PD-1 mAb, HANSIZHUANG (serplulimab, marketed as Hetronifly® in Europe), has been officially approved by the European Commission (EC) ...